Europe Biochip Market, 2026-2033
Europe Biochip Market, 2021-2033 (US$M)
Global Market
Related Markets
Europe biochip market highlights
- The Europe biochip market generated a revenue of USD 4,213.9 million in 2025.
- The market is expected to grow at a CAGR of 11.1% from 2026 to 2033.
- In terms of segment, dna chips was the largest revenue generating type in 2025.
- Lab-on-chip is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, UK is expected to register the highest CAGR from 2026 to 2033.
Europe data book summary
| Market revenue in 2025 | USD 4,213.9 million |
| Market revenue in 2033 | USD 10,059.5 million |
| Growth rate | 11.1% (CAGR from 2026 to 2033) |
| Largest segment | Dna chips |
| Fastest growing segment | Lab-on-chip |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | DNA Chips, Lab-on-chip, Tissue Arrays, Protein Chips, Cell Arrays |
| Key market players worldwide | Agilent Technologies Inc, PerkinElmer, Illumina Inc, Bio-Rad Laboratories Inc, Standard BioTools Inc, GE HealthCare Technologies Inc Common Stock, Thermo Fisher Scientific Inc, Qiagen NV, Randox |
Other key industry trends
- In terms of revenue, Europe region accounted for 27.5% of the global biochip market in 2025.
- Globally, North America is projected to lead the regional market in terms of revenue in 2033.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 7,272.5 million by 2033.
Europe accounts for a considerable revenue share of the biochip market due to the presence of developed economies, such as Germany, Spain, the UK, France, and Italy. These countries have advanced infrastructure, which is anticipated to significantly boost clinical research prospects in the region.
Moreover, the market growth can be attributed to a growing biotechnology industry and rising investments in genomic sequencing in countries such as the UK & Germany. The population in Europe is rapidly aging. According to the UN, individuals aged over 65 make up 19% of the population, which represents approximately 183 million people.
This population is at a higher risk of developing infectious diseases, as they have a greater likelihood of developing flu and being hospitalized. Thus, owing to these factors, the region is expected to witness significant growth opportunities during the forecast period.
No credit card required*
Publish Date: Jun 17, 2026
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Biochips Market
Biochips Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| GE HealthCare Technologies Inc Common Stock | View profile | 51,000 | 500 West Monroe Street, Chicago, IL, United States, 60661 | www.gehealthcare.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Illumina Inc | View profile | 9,300 | 5200 Illumina Way, San Diego, CA, United States, 92122 | www.illumina.com |
| Agilent Technologies Inc | View profile | 17,700 | 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 | www.agilent.com |
| Bio-Rad Laboratories Inc | View profile | 8,030 | 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 | www.bio-rad.com |
| Qiagen NV | View profile | 5,900 | Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL | www.qiagen.com |
| Standard BioTools Inc | View profile | 539 | 2 Tower Place, Suite 2000, South San Francisco, CA, United States, 94080 | www.standardbio.com |
| PerkinElmer | View profile | 10001+ | Waltham, Massachusetts, United States, North America | www.perkinelmer.com |
| Randox | View profile | 1001-5000 | Crumlin, Antrim, United Kingdom, Europe | www.randox.com |
Europe biochips market
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Biochip Market will help companies and investors design strategic landscapes.
Dna Chips was the largest segment with a revenue share of 42.9% in 2025.
Horizon Databook has segmented the Europe biochip market based on dna chips, lab-on-chip, tissue arrays, protein chips, cell arrays covering the revenue growth of each sub-segment from 2021 to 2033.
Europe accounts for a considerable revenue share of the biochip market due to the presence of developed economies, such as Germany, Spain, the UK, France, and Italy. These countries have advanced infrastructure, which is anticipated to significantly boost clinical research prospects in the region.
Moreover, the market growth can be attributed to a growing biotechnology industry and rising investments in genomic sequencing in countries such as the UK & Germany. The population in Europe is rapidly aging. According to the UN, individuals aged over 65 make up 19% of the population, which represents approximately 183 million people.
This population is at a higher risk of developing infectious diseases, as they have a greater likelihood of developing flu and being hospitalized. Thus, owing to these factors, the region is expected to witness significant growth opportunities during the forecast period.
- Europe Biochip Market Type Outlook (Revenue, USD Million , 2021-2033)
- DNA Chips
- Protein Chips
- Lab-on-chip
- Tissue Arrays
- Cell Arrays
- Europe Biochip Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Biotechnology and Pharmaceutical Companies
- Hospitals and Diagnostics Centers
- Academic & Research Institutes
- Others
Reasons to subscribe to biochips market databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of biochips market databook
- Our clientele includes a mix of biochips market companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe biochips market, including forecasts for subscribers. This continent databook contains high-level insights into Europe biochips market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Europe Biochip Market, 2021-2033 (US$M)
Europe Type - Biochip Market, 2025 - 2033 (US$M)
